Clinical Trials

NCT05738538 | AVAILABLE

Expanded Access to Ziftomenib

Study Type:
EXPANDED_ACCESS
Last Updated:
2026-06-29
Conditions
  • Acute Lymphoblastic Leukemia, With KMT2A Rearrangements
  • Acute Myeloid Leukemia, With NPM1 Mutations
  • Acute Myeloid Leukemia, With KMT2A Rearrangements
Interventions
  • DRUG
No Results Yet
NCT05677802 | RECRUITING | NA
40 participants

Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-29
Start Date:
2022-12-14
Completion:
2026-12-31
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Hormone Receptor-Negative Breast Carcinoma
  • Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • OTHER
No Results Yet
NCT05520099 | ACTIVE_NOT_RECRUITING
416 participants

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-29
Start Date:
2023-06-26
Completion:
2027-01-31
Conditions
  • Immunotherapy
  • Cancer
  • Bladder Cancer
  • Urothelial Carcinoma Bladder
  • Kidney Cancer
  • Clear Cell Renal Cell Cancer (ccRCC)
  • Colorectal Cancer
  • MSI-H Colorectal Cancer
  • DMMR Colorectal Cancer
  • Head and Neck Cancer (H&N)
  • Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
  • Liver Cancer
  • Hepatocellular Carcinoma (HCC)
  • Lung Cancer (NSCLC)
  • NSCLC (Non-small Cell Lung Cancer)
  • Skin Cancer
  • Cutaneous Melanoma
  • Endometrial Cancer
  • Solid Tumor Cancer
Interventions
  • PROCEDURE
No Results Yet
NCT05478720 | RECRUITING | PHASE1/PHASE2
152 participants

DON in Pediatric Cerebral Malaria

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-29
Start Date:
2022-08-16
Completion:
2026-12-31
Conditions
  • Malaria, Cerebral
Interventions
  • DRUG
No Results Yet
NCT05402384 | NOT_YET_RECRUITING | PHASE2
10 participants

AVTX-801 D-galactose Supplementation in SLC35A2-CDG

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-29
Start Date:
2027-01-31
Completion:
2028-03-31
Conditions
  • SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page